Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Melanoma is a paradigm of aggressive tumors with a complex and heterogeneous genetic background. Still, melanoma cells frequently retain developmental traits that trace back to lineage specification programs. In particular, lysosome-associated vesicular trafficking is emerging as a melanoma-enriched lineage dependency. However, the contribution of other lysosomal functions such as autophagy to melanoma progression is unclear, particularly in the context of metastasis and resistance to targeted therapy. Here we mined a broad spectrum of cancers for a meta-analysis of mRNA expression, copy number variation and prognostic value of 13 core autophagy genes. This strategy identified heterozygous loss of ATG5 at chromosome band 6q21 as a distinctive feature of advanced melanomas. Importantly, partial ATG5 loss predicted poor overall patient survival in a manner not shared by other autophagy factors and not recapitulated in other tumor types. This prognostic relevance of ATG5 copy number was not evident for other 6q21 neighboring genes. Melanocyte-specific mouse models confirmed that heterozygous (but not homozygous) deletion of Atg5 enhanced melanoma metastasis and compromised the response to targeted therapy (exemplified by dabrafenib, a BRAF inhibitor in clinical use). Collectively, our results support ATG5 as a therapeutically relevant dose-dependent rheostat of melanoma progression. Moreover, these data have important translational implications in drug design, as partial blockade of autophagy genes may worsen (instead of counteracting) the malignant behavior of metastatic melanomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Atg5 LOH increases melanoma metastasis in vivo in a BRAFV600E and PTEN-deficient mouse model93.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [93]
In the citing paper
“Atg5 loss of heterozygosity is found in many advanced melanomas and correlates with poor overall survival93.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · cited 1×
“mRNA expression of these genes was first screened through the Cancer Cell Line Encyclopedia (CCLE), which encompasses 61 cell lines from melanoma and 856 lines of over 22 different cancer types.(43) Hematopoietic tumors showed a distinct gene expression pattern with a consistent downregulation of GABARAPL1 andMAP1LC3A…”
BackgroundMutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Antimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,164
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationEaten alive: a history of macroautophagy
Yang, Z., & Klionsky, D. J. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-814 · Cited by 2,095
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
Network organization of the human autophagy system
Behrends, C., Sowa, M. E., Gygi, S. P., & Harper, J. W. (2010) · Nature · doi:10.1038/nature09204 · Cited by 1,554 · cited 3×
“These networks are in turn, further influenced by multiple context-dependent feedback and feedforward signaling cascades.(46,69) Dissecting the impact of”
BackgroundGarraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Amaravadi, R. K., Yu, D., Lum, J. J., Bui, T., Christophorou, M. A., Evan, G. I., Thomas-Tikhonenko, A., & Thompson, C. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28833 · Cited by 1,137
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Self-citationThe Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Van Allen, E. M., Wagle, N., Sucker, A., Treacy, D. J., Johannessen, C. M., Goetz, E. M., Place, C. S., Taylor-Weiner, A., Whittaker, S., Kryukov, G. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0617 · Cited by 912
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Müller, J., Krijgsman, O., Tsoi, J., Robert, L., Hugo, W., Song, C., Kong, X., Possik, P. A., Cornelissen-Steijger, P. D. M., Foppen, M. H. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms6712 · Cited by 639
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Caramel, J., Papadogeorgakis, E., Hill, L., Browne, G. J., Richard, G., Wierinckx, A., Saldanha, G., Osborne, J., Hutchinson, P., Tse, G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.018 · Cited by 517
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Bastian, B. C. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104658 · Cited by 513
Melanoma: from mutations to medicine
Tsao, H., Chin, L., Garraway, L. A., & Fisher, D. E. (2012) · Genes & Development · doi:10.1101/gad.191999.112 · Cited by 496 · cited 2×
“For example, hyperactivation of RAS>BRAF>MEK, PIK3CA>AKT, NOTCH or SHH signaling pathways, as well as downregulation of PTEN or functional inhibition of p53 are few examples of “classical” tumorigenic events accumulated, albeit with varied incidence, in multiple neoplasias, including melanoma.(2,3) Cancer hallmarks ca…”
BackgroundAn integrated approach to uncover drivers of cancer
Akavia, U. D., Litvin, O., Kim, J., Sanchez-Garcia, F., Kotliar, D., Causton, H. C., Pochanard, P., Mozes, E., Garraway, L. A., & Pe'er, D. (2010) · Cell · doi:10.1016/j.cell.2010.11.013 · Cited by 484
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Johannessen, C. M., Johnson, L. A., Piccioni, F., Townes, A., Frederick, D. T., Donahue, M. K., Narayan, R., Flaherty, K. T., Wargo, J. A., Root, D. E., et al. (2013) · Nature · doi:10.1038/nature12688 · Cited by 452
A dual role for autophagy in a murine model of lung cancer
Rao, S., Tortola, L., Perlot, T., Wirnsberger, G., Novatchkova, M., Nitsch, R., Sykacek, P., Frank, L., Schramek, D., Komnenovic, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms4056 · Cited by 442
Tumor Vessel Normalization by Chloroquine Independent of Autophagy
Maes, H., Kuchnio, A., Peric, A., Moens, S., Nys, K., De Bock, K., Quaegebeur, A., Schoors, S., Georgiadou, M., Wouters, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.025 · Cited by 410
Adhesion, migration and communication in melanocytes and melanoma
Haass, N. K., Smalley, K. S. M., Li, L., & Herlyn, M. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00235.x · Cited by 388
Lineage dependency and lineage-survival oncogenes in human cancer
Garraway, L. A., & Sellers, W. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1947 · Cited by 360
Denoyelle, C., Abou-Rjaily, G., Bezrookove, V., Verhaegen, M., Johnson, T. M., Fullen, D. R., Pointer, J. N., Gruber, S. B., Su, L. D., Nikiforov, M. A., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1471 · Cited by 349
Self-citationFeng, Y., Yao, Z., & Klionsky, D. J. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.02.002 · Cited by 296
Whiteman, D. C., Pavan, W. J., & Bastian, B. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00880.x · Cited by 273
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells
Ploper, D., Taelman, V. F., Robert, L., Perez, B. S., Titz, B., Chen, H.-W., Graeber, T. G., von Euw, E., Ribas, A., & De Robertis, E. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424576112 · Cited by 228 · cited 2×
“dependent vesicular trafficking was found to represent an inherent vulnerability of melanoma cells,(24) a concept supported by independent studies.(11,27) The specific contribution of other”
BackgroundResultMelanoma and the tumor microenvironment
Villanueva, J., & Herlyn, M. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0067-y · Cited by 219
The Transcription Network Regulating Melanocyte Development and Melanoma
Vance, K. W., & Goding, C. R. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00164.x · Cited by 209
Atg7 Overcomes Senescence and Promotes Growth of Braf V600E-Driven Melanoma
Xie, X., Koh, J. Y., Price, S., White, E., & Mehnert, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1473 · Cited by 208 · cited 6×
“In turn, ATG7 and ATG5 may have opposing roles in melanoma initiation.(39,40) Although ATG7 gene expression has not been formally analyzed in human melanomas, targeted deletions in mice (i.”
BackgroundMethodInfluentialPinner, S., Jordan, P., Sharrock, K., Bazley, L., Collinson, L., Marais, R., Bonvin, E., Goding, C., & Sahai, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0781 · Cited by 202
Marino, S., Krimpenfort, P., Leung, C., van der Korput, H. A. G. M., Trapman, J., Camenisch, I., Berns, A., & Brandner, S. (2002) · Development · doi:10.1242/dev.129.14.3513 · Cited by 196
Liu, H., He, Z., von Rütte, T., Yousefi, S., Hunger, R. E., & Simon, H.-U. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005864 · Cited by 188 · cited 5×
“In turn, ATG7 and ATG5 may have opposing roles in melanoma initiation.(39,40) Although ATG7 gene expression has not been formally analyzed in human melanomas, targeted deletions in mice (i.”
BackgroundMethodInfluentialThe genetics of uveal melanoma: an emerging framework for targeted therapy
Harbour, J. W. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00979.x · Cited by 178
Tormo, D., Chęcińska, A., Alonso-Curbelo, D., Pérez-Guijarro, E., Cañón, E., Riveiro-Falkenbach, E., Calvo, T. G., Larribere, L., Megías, D., Mulero, F., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.004 · Cited by 178
Self-citationKarube, K., Nakagawa, M., Tsuzuki, S., Takeuchi, I., Honma, K., Nakashima, Y., Shimizu, N., Ko, Y.-H., Morishima, Y., Ohshima, K., et al. (2011) · Blood · doi:10.1182/blood-2011-04-346890 · Cited by 167
Corazzari, M., Rapino, F., Ciccosanti, F., Giglio, P., Antonioli, M., Conti, B., Fimia, G. M., Lovat, P. E., & Piacentini, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.183 · Cited by 162
Autophagy in cutaneous malignant melanoma
Lazova, R., Klump, V., & Pawelek, J. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01359.x · Cited by 139
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Miracco, C., Cevenini, G., Franchi, A., Luzi, P., Cosci, E., Mourmouras, V., Monciatti, I., Mannucci, S., Biagioli, M., Toscano, M., et al. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.09.004 · Cited by 139
Cross-cancer profiling of molecular alterations within the human autophagy interaction network
Lebovitz, C. B., Robertson, A. G., Goya, R., Jones, S. J., Morin, R. D., Marra, M. A., & Gorski, S. M. (2015) · Autophagy · doi:10.1080/15548627.2015.1067362 · Cited by 132
Marzese, D. M., Scolyer, R. A., Huynh, J. L., Huang, S. K., Hirose, H., Chong, K. K., Kiyohara, E., Wang, J., Kawas, N. P., Donovan, N. C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt420 · Cited by 122
Alonso‐Curbelo, D., Riveiro‐Falkenbach, E., Pérez‐Guijarro, E., Cifdaloz, M., Karras, P., Osterloh, L., Megías, D., Cañón, E., Calvo, T. G., Olmeda, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.030 · Cited by 121
Self-citationIdentification of secreted proteins that reflect autophagy dynamics within tumor cells
Kraya, A. A., Piao, S., Xu, X., Zhang, G., Herlyn, M., Gimotty, P., Levine, B., Amaravadi, R. K., & Speicher, D. W. (2015) · Autophagy · doi:10.4161/15548627.2014.984273 · Cited by 121
Chromosome 6q involvement in human malignant melanoma
Trent, J. M., Rosenfeld, S. B., & Meyskens, F. L. (1983) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(83)90039-0 · Cited by 116
Chromosome 6p amplification and cancer progression
Santos, G. C., Zieleńska, M., Prasad, M., & Squire, J. A. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.034389 · Cited by 111
Goodall, M. L., Wang, T., Martin, K. R., Kortus, M. G., Kauffman, A. L., Trent, J. M., Gately, S., & MacKeigan, J. P. (2014) · Autophagy · doi:10.4161/auto.28594 · Cited by 108
Javelaud, D., Alexaki, V. I., Pierrat, M., Hoek, K. S., Dennler, S., van Kempen, L. C. L. T., Bertolotto, C., Ballotti, R., Saule, S., Delmas, V., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00893.x · Cited by 104
Luke, J. J., & Hodi, F. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0391 · Cited by 101
Thurber, A. E., Douglas, G., Sturm, E. C., Zabierowski, S. E., Smit, D. J., Ramakrishnan, S. N., Hacker, E., Leonard, J. H., Herlyn, M., & Sturm, R. A. (2011) · Oncogene · doi:10.1038/onc.2011.33 · Cited by 96
Spatiotemporal gene control by the Cre‐ERT2 system in melanocytes
Yajima, I., Belloir, E., Bourgeois, Y., Kumasaka, M., Delmas, V., & Larue, L. (2006) · genesis · doi:10.1002/gene.20182 · Cited by 90
Hoshimoto, S., Kuo, C. T., Chong, K. K., Takeshima, T., Takei, Y., Li, M. W., Huang, S. K., Sim, M., Morton, D. L., & Hoon, D. S. �. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.36 · Cited by 89
Maddodi, N., Huang, W., Havighurst, T., Kim, K., Jack Longley, B., & Setaluri, V. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.26 · Cited by 80 · cited 2×
“The extent to which ATG5 contributes to melanoma metastasis is confounded by reports where both depletion and overexpression of this protein compromise the tumorigenic potential of culturedmelanoma cell lines.(30,39)”
BackgroundZhang, T., Zhou, Q., Ogmundsdottir, M. H., Möller, K., Siddaway, R., Larue, L., Hsing, M., Kong, S. W., Goding, C., Palsson, A., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.173807 · Cited by 78
Sivridis, E., Koukourakis, M. I., Mendrinos, S. E., Karpouzis, A., Fiska, A., Kouskoukis, C., & Giatromanolaki, A. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e328346612c · Cited by 73
The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA
Bell, R. E., & Levy, C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00931.x · Cited by 68
Flaherty, K. T. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-050410-105655 · Cited by 64
Martin, S., Dudek-Perić, A. M., Maes, H., Garg, A. D., Gabrysiak, M., Demirsoy, S., Swinnen, J. V., & Agostinis, P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.003 · Cited by 54
Autophagy and mitophagy interplay in melanoma progression
Maes, H., & Agostinis, P. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.003 · Cited by 53
The stressful road to antibody secretion
Ma, Y., & Hendershot, L. M. (2003) · Nature Immunology · doi:10.1038/ni0403-310 · Cited by 52
Kim, M., Jang, H.-R., Haam, K., Kang, T.-W., Kim, J., Kim, S., Noh, S., Song, K., Cho, J.-S., Jeong, H. Y., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq144 · Cited by 50
MITF, the Janus Transcription Factor of Melanoma
Koludrovic, D., & Davidson, I. (2013) · Future Oncology · doi:10.2217/fon.12.177 · Cited by 42
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development
Alonso‐Curbelo, D., Osterloh, L., Cañón, E., Calvo, T. G., Martínez-Herranz, R., Karras, P., Martínez, S., Riveiro‐Falkenbach, E., Romero, P. L. O., Rodríguez‐Peralto, J. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4055 · Cited by 28
Self-citationThe gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy
Chęcińska, A., & Soengas, M. S. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00927.x · Cited by 27
Self-citationWang, L., Wang, Y., Lu, Y.-Y., Zhang, Q., & Qu, X. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002331 · Cited by 24
Melanoma genetics: the other side
Bis, S., & Tsao, H. (2013) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2012.08.003 · Cited by 17
Targeting Autophagy in BRAF-Mutant Tumors
Thorburn, A. M., & Morgan, M. J. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0222 · Cited by 15
Hyperactivated endolysosomal trafficking in melanoma
Alonso‐Curbelo, D., & Soengas, M. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3141 · Cited by 14
Self-citationUnmet needs in melanoma research
Aplin, A. E., Bosenberg, M., Soengas, M. S., Kos, L., Arnheiter, H., & Kelsh, R. N. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12321 · Cited by 2
Self-citation
Cited by
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 404
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
The multifaceted role of autophagy in cancer
Russell, R. C., & Guan, K. (2022) · The EMBO Journal · doi:10.15252/embj.2021110031 · Cited by 222
Mechanisms and context underlying the role of autophagy in cancer metastasis
Dower, C. M., Wills, C. A., Frisch, S. M., & Wang, H.-G. (2018) · Autophagy · doi:10.1080/15548627.2018.1450020 · Cited by 198
Metadata
- Authors
- García-Fernández, M., Karras, P., Checinska, A., Cañón, E., Calvo, G. T., Gómez-López, G., Cifdaloz, M., Colmenar, A., Espinosa-Hevia, L., Olmeda, D., & Soengas, M. S.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)
- Spanish National Cancer Research Centre (CNIO)
- Spanish National Cancer Research Center (CNIO)
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2016-07-27
- Volume
- 12
- Issue
- 10
- Pages
- 1776-1790
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- PMC
- PMC5079679
- OpenAlex
- W2478143017
- Cited by
- 35
- References
- 79
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 3
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Autophagy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Melanoma Research Alliance
- Centro de Biología Molecular Severo Ochoa
- Centro Nacional de Investigaciones Cardiovasculares
- Tokyo Medical and Dental University
- University of California, San Francisco
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- melanoma, ATG5, loss of heterozygosity, 6q21, BRAF inhibitors, dabrafenib, drug resistance, metastasis, copy number variation, prognostic factors, melanocyte lineage, lysosomal trafficking, autophagy-related genes
- MeSH terms
- Autophagy-Related Protein 5, Animals, Autophagy, Chromosome Mapping, Disease Models, Animal, Heterozygote, Melanoma, Neoplasm Metastasis, Nevus, Pigmentation, Prognosis, Promoter Regions, Genetic, Risk Factors, RNA, Messenger, Down-Regulation, Gene Expression Regulation, Neoplastic, Survival Analysis, Drug Resistance, Neoplasm, DNA Methylation, Loss of Heterozygosity, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, Mice, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.